| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 916.00M | 1.03B | 1.14B | 1.32B | 1.41B | 1.62B |
| Gross Profit | 483.00M | 579.00M | 944.00M | 1.12B | 1.23B | 1.47B |
| EBITDA | 722.00M | 906.00M | 801.00M | 803.00M | 788.00M | 1.29B |
| Net Income | 242.00M | 365.00M | 536.00M | 501.00M | 658.00M | 756.00M |
Balance Sheet | ||||||
| Total Assets | 28.13B | 28.86B | 27.71B | 26.87B | 26.20B | 24.78B |
| Cash, Cash Equivalents and Short-Term Investments | 11.26B | 11.84B | 11.00B | 9.98B | 9.40B | 8.18B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 684.00M | 867.00M | 1.06B | 1.19B | 1.30B | 1.52B |
| Stockholders Equity | 25.86B | 26.32B | 25.16B | 24.30B | 23.65B | 22.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 130.00M | 702.00M | 421.00M | 538.00M | 946.00M |
| Operating Cash Flow | 0.00 | 473.00M | 744.00M | 630.00M | 539.00M | 947.00M |
| Investing Cash Flow | 0.00 | -530.00M | -258.00M | -334.00M | -874.00M | -375.00M |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | -199.00M | 1.00M | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.80B | 10.05 | 17.21% | 4.27% | 11.13% | 20.95% | |
72 Outperform | ¥2.09T | 3.01 | 20.02% | 2.63% | 31.37% | 148.24% | |
70 Outperform | ¥41.53B | 10.52 | 6.18% | 4.42% | 30.88% | 193.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥174.85B | 10.82 | 7.40% | 5.60% | 15.68% | 49.07% | |
53 Neutral | ¥24.37B | -8.03 | ― | ― | -45.54% | -286.03% | |
44 Neutral | ¥20.66B | 169.87 | ― | 1.85% | -39.21% | -56.51% |